Sudan

| High HIV burden |

Population 2011 Estimates of TB burden * 2011 Mortality (excludes HIV+TB) Prevalence (includes HIV+TB) Incidence (includes HIV+TB) Incidence (HIV+TB only) Case detection, all forms (%) TB case notifications 2011 New cases Smear-positive Smear-negative Smear-unknown / not done Extrapulmonary Other Total new Other (history unknown) Total new and relapse Number (thousands) 7.5 (3.214) 69 (34120) 40 (3348) 2.8 (2.13.6) 48 (4159)

Tuberculosis profile
(Rate per 100 000 population per year) 34 million *** 100 Rate 80 (per 100 000 population) 60 22 (9.240) 40 201 (98339) 20 117 (96139) 0 8.2 (6.211) 1990 1994 1998 2002 2006
___

Mortality (excludes HIV+TB)

7 266 5 294 1 452 4 624 0 18 636 0 19 348

(%) (39) (28) (8) (25) (0)

Retreatment cases Relapse Treatment after failure Treatment after default Other Total retreatment

712 145 733 159 1 749

(%) (41) (8) (42) (9)

(Rate per 100 000 population) 600 400 200 0 1990

___

1994

1998

2002

2006

Prevalence

Total cases notified Smear-negative/ unknown/ not done 1.6 1 627

20 385 (Rate per 100 000 population per year) 250 200 150 100 50 0 1990

New cases M:F ratio Age < 15

Smear-positive 1.9 220

Extrapulmonary 1.3 737 2011 0.7 0.1 0.1 Yes, in country Yes

Laboratories Smear (per 100 000 population) Culture (per 5 million population) Drug susceptibility testing (per 5 million population) Is second-line drug susceptibility testing available? Is there a national reference laboratory? Treatment success rate 2010 (%) New smear-positive and/or culture-positive New smear-negative/extrapulmonary Retreatment

1994

1998

2002

2006

__
___

Notifications ___ Incidence Incidence (HIV+TB only)

Treatment success rate (%) 80

80 71 68

Is rifampicin used throughout treatment for new patients? Number 3 082 292 0 292

60 Yes 40 (%) (15) (9) (0) (100) 20 1995 1997 1999 2001 2003 2005 2007 2009

TB/HIV 2011 TB patients with known HIV status HIV-positive TB patients HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) HIV-positive TB patients on antiretroviral therapy (ART) HIV-positive people screened for TB HIV-positive people provided with IPT Estimates of MDR-TB burden 2011* % of TB cases with MDR-TB MDR-TB cases among notified pulmonary TB cases Reported cases of MDR-TB 2011 Cases tested for MDR-TB Laboratory-confirmed MDR-TB cases Patients started on MDR-TB treatment Financing TB control Total budget (US$ millions) Available funding (US$ millions) % of budget funded % available funding from domestic sources % available funding from the Global Fund New 1.8 (0.53.1) 250 (70430) New 36 (<1%) 13

__ New smear-positive and/or culture-positive __New smear-negative/extrapulmonary __

Retreatment (Number of patients)

Retreatment 19 (6.632) 340 (120550)

600 400 200

Retreatment 82 (5%) 40

Total 135 62 80 2013 9.6 5.6 58 1 96

0 2003 2004 2005 2006 2007 2008 2009 2010

__ HIV-positive TB patients __on CPT __on ART

(US$ millions) 14 10 6 2 2006 2007 2008 2009 2010 2011 2012

2012 7.4 5 68 2 95

__

Total budget

__Available funding

* Ranges represent uncertainty intervals

Generated: 2013-03-29

Data: www.who.int/tb/data